Supplement Library
FULL SUPPLEMENT: Incorporating Cosmeceuticals in In-Office Aesthetic Procedures for Skin of Color
April 2025 | Volume 24 | Issue 4 | Department | 41490s1 | Copyright © April 2025
Common signs of skin aging include wrinkles, fine lines, and pigmentary disorders. Patients with skin of color present with unique dermatologic challenges due to differences in how skin conditions man...
Read MoreINDIVIDUAL ARTICLE: Breaking Barriers: Advancing Cosmeceuticals and Integrated Skincare for Skin of Color
April 2025 | Volume 24 | Issue 4 | Supplement Individual Articles | 41491s5 | Copyright © April 2025
Common signs of skin aging include wrinkles, fine lines, and pigmentary disorders. Patients with skin of color present with unique dermatologic challenges due to differences in how skin condition...
Read MoreFULL SUPPLEMENT: United States Cutaneous Oncodermatology Management (USCOM ) V: A Multidisciplinary-Guided Algorithm for Preventing and Managing Cutaneous Hormonal Therapy-Related Adverse Events in Cancer Patients
April 2025 | Volume 24 | Issue 4 | Department | 84820s1 | Copyright © April 2025
Although cancer incidence continues to rise, advancements in treatment options have contributed to the decline in cancer mortality.1,3 Hormonal therapy is a mainstay treatment for the management of ho...
Read MoreINDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
April 2025 | Volume 24 | Issue 4 | Supplement Individual Articles | 84821s3 | Copyright © April 2025
Introduction: In 2024, over 2 million patients will be diagnosed with cancer in the United States, with prostate cancer and breast cancer representing the leading diagnoses in me...
Read MoreFULL SUPPLEMENT: Exploring The Scalp Barrier and Microbiome In Diverse Dandruff Patients
March 2025 | Volume 24 | Issue 3 | Department | 32730s1 | Copyright © March 2025
Although the exact pathophysiology of dandruff is still not completely decoded, current theories highlight the role of the microbiome on the skin surface in the patho-genesis. Several scalp microbiome...
Read MoreINDIVIDUAL ARTICLE: A Clinical Evaluation of Scalp Barrier Function, Ceramide Levels, and Microbiome in Diverse Dandruff Patients
March 2025 | Volume 24 | Issue 3 | Supplement Individual Articles | 32731s3 | Copyright © March 2025
Dandruff is a common chronic scalp condition that affects approximately half the population irrespective of their origin. Dandruff scalps are characterized by flaking skin, pruritus, and minimal ...
Read MoreFULL SUPPLEMENT: Nordic European Cutaneous Oncodermatology Management (Necom) 5: A Practical Algorithm for the Treatment And Supportive Management of Cutaneous Adverse Events in Patients Receiving Targeted Therapy for Cancer
March 2025 | Volume 24 | Issue 3 | Department | 88540s1 | Copyright © March 2025
Although cancer incidences seemingly continue to rise, ongoing advancements in cancer therapy have simultaneously contributed to improved survival. Nordic survival studies from the past decades have s...
Read MoreINDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse Events
March 2025 | Volume 24 | Issue 3 | Supplement Individual Articles | 88541s3 | Copyright © March 2025
Background: The cancer burden in the Nordic European countries remains substantial, but new treatment approaches, such as targeted therapy, have increased the survival of cancer ...
Read MoreFULL SUPPLEMENT: Scalp Health & the Role of the Scalp Barrier in Dandruff and Seborrheic Dermatitis
February 2025 | Volume 24 | Issue 2 | Department | 32710 | Copyright © February 2025
Research has shown that scalp and hair health are connected, but the link is not yet fully understood or characterized. Hair growth begins within the hair follicle, about 4 mm deep in the skin.1<...
Read MoreINDIVIDUAL ARTICLE: Insights on the Impact of Scalp Barrier Condition on Hair Health
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s3 | Copyright © February 2025
Scalp health is essential for healthy hair growth and may be affected by intrinsic or extrinsic factors. Reactive oxygens species are key contributors to aging and can have a detrimental impact o...
Read MoreINDIVIDUAL ARTICLE: Etiology, Treatment Challenges, and the Role of Scalp and Haircare in Managing Dandruff
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s8 | Copyright © February 2025
Dandruff and seborrheic dermatitis are associated with a disrupted scalp barrier that contributes to irritation, pruritus, and flaking of the scalp. The flaking and itch associated with dandruff ...
Read MoreFULL SUPPLEMENT: Masterful Topical JAK Inhibitor
February 2025 | Volume 24 | Issue 2 | Department | 49140 | Copyright © February 2025
Janus kinase (JAK) inhibitors, which have been used in a range of disease states from rheumatology to gastroenterology, have been finally adopted into dermatology. These agents are rapidly changing th...
Read MoreINDIVIDUAL ARTICLE: VEHICLES MATTER: DESIGNED FOR PURPOSE
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | 49141 | Copyright © February 2025
INDIVIDUAL ARTICLE: Appraisal of Ruxolitinib 1.5% Cream as a First-Line Topical Therapeutic Agent for Adolescents and Adults With Mild-to-Moderate Atopic Dermatitis
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s5 | Copyright © February 2025
Dermatology has entered the long-awaited paradigm shift from steroidal to non-steroidal therapeutics for the topical treatment of atopic dermatitis. Topical Janus kinase (JAK) inhibitors have gar...
Read MoreINDIVIDUAL ARTICLE: Ruxolitinib 1.5% Cream and the "Boxed Warning Paradox": Reappraisal of Safety Through the Lens of Pharmacokinetics
February 2025 | Volume 24 | Issue 2 | Supplement Individual Articles | s16 | Copyright © February 2025
Ruxolitinib 1.5% cream is the first-in-class topical Janus kinase (JAK) inhibitor approved for the treatment of atopic dermatitis in patients 12 years of age and older. The US Food and Drug Admin...
Read MoreFULL SUPPLEMENT: Obesity: The Impact on Biologic Selection
January 2025 | Volume 24 | Issue 1 | Department | 491710s1 | Copyright © January 2025
Obesity is a multifactorial disease with a rapidly increasing global prevalence. Its etiology is driven by a chronic imbalance between energy intake and energy expenditure. Excess energy is stored in ...
Read MoreINDIVIDUAL ARTICLE: Psoriasis Is a Systemic Disease
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491711s2 | Copyright © January 2025
INDIVIDUAL ARTICLE: Psoriasis and Obesity: Optimizing Pharmacologic Treatment and Lifestyle Interventions
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 491722s4 | Copyright © January 2025
Obesity is a metabolic disease that is marked by excessive fat accumulation and is objectively defined as a body mass index (BMI) ≥30 kg/m2. Obesity is associated with several other...
Read MoreFULL SUPPLEMENT: Real-World Cases Using Topical Clascoterone Cream in Acne
January 2025 | Volume 24 | Issue 1 | Department | 733610s1 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lead to ...
Read MoreINDIVIDUAL ARTICLE: Real-World Cases of Clascoterone Topical Treatment for Acne and Related Disorders
January 2025 | Volume 24 | Issue 1 | Supplement Individual Articles | 73361s3 | Copyright © January 2025
Acne vulgaris affects approximately 80% of young adults and adolescents in the world. Acne presents as comedones, pustules, papules, and nodules on the face, chest, shoulders, or back. It can lea...
Read More
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
